Our findings support the idea that Orai1 inhibition can improve Ca2+ cycling and systolic cardiac function during hypertrophic stress, suggesting that selective Orai1 blockade might provide a new therapy for cardiac hypertrophy and HF. This evidence concerns the gene ORAI1 and cardiac hypertrophy.